Heartburn
71
5
6
56
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
21 trials with published results (30%)
Research Maturity
56 completed trials (79% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
2.8%
2 terminated out of 71 trials
96.6%
+10.0% vs benchmark
41%
29 trials in Phase 3/4
38%
21 of 56 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 56 completed trials
Clinical Trials (71)
New Topical tReatment Options for Symptomatic patiEnts With Nonerosive gastroesophageaL Reflux dIsease (The RELIEF Trial)
Antireflux Surgery Without Preoperative Esophageal Manometry
A Clinical Trial of PepZinGI® for Acute Heartburn Relief and Sleep Outcomes
Domperidone in Treating Patients With Gastrointestinal Disorders
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
The Effect of the LEFT Smartwatch App as Sleep Positional Therapy for Nocturnal Gastroesophageal Reflux Symptoms.
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Observationa Study is a Prospective and Multi-institutional Observational Study.
A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily
Smartphone App-assisted PPI
Primary carE PPi dEprescRibing Trial
Remote Guided Caffeine Reduction
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers
A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male Participants
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)
Implementation of a Minor Ailment Service in Community Pharmacy Practice
Tolerability Study of Panosyl-Isomaltooligosaccharides (PIMO) and a Placebo in Subjects With Heartburn
Prevalence of Fuctional Heartburn in Patients With IBS .
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease